- Biolase (NASDAQ:BIOL) Q2 results: Revenues: $13.8M (+16.0%); Operating Loss: ($3.4M) (+51.4%); Net Loss: ($3.5M) (+50.0%); Loss Per Share: ($0.06) (+50.0%); Non-GAAP Loss Per Share: ($0.04) (+60.0%); Quick Assets: $4.9M (-58.1%); CF Ops: ($6.3M) (+42.7%).
- No guidance given.
Biolase revenues up 16%; net loss improves in Q2
Recommended For You
More Trending News
About BIOL Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BIOL | - | - |
| BIOLASE, Inc. | ||